Oseltamivir Phosphate For Suspension
Product Images NDC 42291-567

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 42291-567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

567 60

Label for Oseltamivir Phosphate for Oral Suspension 6 mg/mL by AvKARE. The label states the product is an oral suspension with 6 mg/mL strength, provided in a 60 mL container after constitution. Instructions for preparation, storage, and usage are included, highlighting refrigeration requirements and dosage preparation. Manufacturer details and a barcode are visible.*

FDA Label Image

Structural Formula (Oseltamivir Phosphate For Oral Suspension 1)

Chemical structure of Oseltamivir Phosphate, the active ingredient in the oral suspension formulation. The diagram depicts the molecular arrangement including the ethoxy group, amino group with phosphate, and carbamate functional groups characteristic of Oseltamivir Phosphate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.